Apollo Medical (ASTH) EBITDA (2010 - 2026)
Apollo Medical (ASTH) EBITDA from Jul 31, 2010 to Mar 31, 2026. The TTM Apollo Medical (ASTH) EBITDA is $141M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Apollo Medical (ASTH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +28.67% |
| 3 Years TTM | +16.57% |
| 5 Years TTM | +18.16% |
Annual EBITDA change of Apollo Medical (ASTH)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $44M | -64.59% |
| 2025 | $124M | +5.96% |
| 2024 | $117M | +14.58% |
| 2023 | $102M | -15.97% |
| 2022 | $122M | +5.28% |
| 2021 | $116M | +161.59% |
| 2020 | $44M | -12.76% |
| 2019 | $51M | -52.94% |
| 2018 | $108M | +98.71% |
| 2017 | $54M | +81.95% |
| 2016 | $30M | -8377.78% |
| 2015 | -$360K | -33.33% |
| 2014 | -$540K | -73.79% |
| 2013 | -$2.06M | -30.87% |
| 2012 | -$2.98M | -2392.31% |
| 2011 | $130K | -750.00% |
| 2010 | -$20K | N/A |
Comparison Apollo Medical (ASTH) five years EBITDA CAGR with competitors
Apollo Medical (ASTH) five years EBITDA CAGR is 7.97%.